Neuralstem, Inc. (94) | Purchase Agreements (7)
Recent Contracts
-
Form of Securities Purchase Agreement
(Filed With SEC on January 4, 2023)
-
Form of Securities Purchase Agreement, dated May 6, 2022, by and among the Company and the purchasers named therein
(Filed With SEC on May 6, 2022)
-
Securities Purchase Agreement, dated as of August 19, 2021, by and between Palisade Bio, Inc. and Yuma Regional Medical Center
(Filed With SEC on August 24, 2021)
-
Amendment Agreement to Securities Purchase Agreement by and among, the Company, Leading BioSciences, Inc. and Altium Growth Fund, LP, dated May 3, 2021
(Filed With SEC on May 14, 2021)
-
Securities Purchase Agreement, by and between Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020
(Filed With SEC on December 21, 2020)
-
Securities Purchase Agreement, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020
(Filed With SEC on December 21, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 27, 2020)